Tag: LEOPARD trial
Endologix receives US FDA approval of PMA supplement for AFX2 system
Endologix recently announced that it has received US Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2...
Endologix reports five-year data of the LEOPARD trial for the treatment...
Christopher Kwolek (Massachusetts General Hospital and Harvard Medical School, Boston, USA) presented five-year results from the LEOPARD randomised controlled trial (RCT) during a late-breaking...
